Cargando…
A Cancer Cell–Intrinsic GOT2–PPARδ Axis Suppresses Antitumor Immunity
Despite significant recent advances in precision medicine, pancreatic ductal adenocarcinoma (PDAC) remains near uniformly lethal. Although immune-modulatory therapies hold promise to meaningfully improve outcomes for patients with PDAC, the development of such therapies requires an improved understa...
Autores principales: | Abrego, Jaime, Sanford-Crane, Hannah, Oon, Chet, Xiao, Xu, Betts, Courtney B., Sun, Duanchen, Nagarajan, Shanthi, Diaz, Luis, Sandborg, Holly, Bhattacharyya, Sohinee, Xia, Zheng, Coussens, Lisa M., Tontonoz, Peter, Sherman, Mara H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533011/ https://www.ncbi.nlm.nih.gov/pubmed/35894778 http://dx.doi.org/10.1158/2159-8290.CD-22-0661 |
Ejemplares similares
-
Acidic fibroblast growth factor underlies microenvironmental regulation of MYC in pancreatic cancer
por: Bhattacharyya, Sohinee, et al.
Publicado: (2020) -
Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer–Associated Fibroblasts
por: Helms, Erin J., et al.
Publicado: (2022) -
Preserved glucose tolerance in high-fat-fed C57BL/6 mice transplanted with PPARγ(−/−), PPARδ(−/−), PPARγδ(−/−), or LXRαβ(−/−) bone marrow
por: Marathe, Chaitra, et al.
Publicado: (2009) -
Fibroblasts as Modulators of Local and Systemic Cancer Metabolism
por: Sanford-Crane, Hannah, et al.
Publicado: (2019) -
NO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδ Contribute to Colon Carcinogenesis?
por: Mackenzie, Gerardo G., et al.
Publicado: (2008)